Skip to content

Ekso vs Sentante Endovascular Robotic System

Side-by-side comparison of Ekso (Ekso Bionics) and Sentante Endovascular Robotic System (Sentante) — specs, pricing, Robo Index, and verified deployments. Updated daily.

Prices in
View saved

Optimized for Agriculture buyers. Priority specs lifted to the top and marked with a target.

Layer 1: Identity & Trust

Manufacturer Country

  • Ekso
    EksoUnited States
  • Sentante Endovascular Robotic SystemLT

Year First Available

  • Ekso
    Ekso2010
  • Sentante Endovascular Robotic System2026

Verified Deployments

  • Ekso
    Ekso0 Deployments
  • Sentante Endovascular Robotic System0 Deployments

Layer 2: Operational

Price

  • Ekso
    Ekso$130,000 USD
  • Sentante Endovascular Robotic SystemContact for quote

Availability Status

  • Ekso
    EksoACTIVE
  • Sentante Endovascular Robotic SystemACTIVE

Layer 3: Category Specific

Max Speed

  • Ekso
    Ekso0.5 m/s
  • Sentante Endovascular Robotic System

Autonomy Level

  • Ekso
    Eksofully autonomous
  • Sentante Endovascular Robotic System

Insufficient data for full comparison

The following fields had no data for any of the selected robots: Battery / Shift Runtime, Payload Capacity, Reach, IP Rating

best in categoryweakest in categoryvalues differ

ROI Comparison

Same operating assumptions across every robot — the only difference is price. Set your numbers once to see which pays back fastest.

Annual labor displaced (per robot): $50,000

MetricEksoSentante Endovascular Robotic System
Investment$130,000No price
Payback period31.2 mo
Net savings (5 yr)$120,000
ROI (5 yr)+92%

Sentante Endovascular Robotic System has no listed price, so payback can't be computed. Contact the manufacturer for a quote.

Estimates labor-cost displacement only — not a full total cost of ownership. Actual ROI depends on integration, maintenance, training, downtime, and task fit. Converted currencies are indicative; USD is the price of record.

Trade-offs at a glance

Frequently asked

Who makes Ekso and Sentante Endovascular Robotic System?

Ekso is made by Ekso Bionics, based in US. Sentante Endovascular Robotic System is made by Sentante, based in LT.

When were Ekso and Sentante Endovascular Robotic System launched?

Ekso launched in 2010. Sentante Endovascular Robotic System launched in 2026.

How do Ekso and Sentante Endovascular Robotic System compare on the Robo Index?

Ekso grades AA on the Robo Index. Sentante Endovascular Robotic System grades BBB. The Robo Index is a credibility grade (AAA … C) that blends commercial maturity, verified deployments, company standing, and independent coverage — see methodology for the full breakdown.

Are Ekso and Sentante Endovascular Robotic System in the same category?

Both robots are classified as Surgical Medical on Robolist. Filters and ranking treat them as direct alternatives.

What is the realistic total cost of ownership for Surgical Medical robots?

Hardware cost is one input. Surgical Medical TCO also includes integration, training, downtime, and end-of-life. Our breakdown: Surgical Robot TCO: Capital, Consumables, Training, and Per-Procedure Cost.

What should a buyer ask vendors when choosing between Ekso and Sentante Endovascular Robotic System?

Spec sheets only show part of the story. Useful vendor questions cover support, lifecycle, integration cost, and references. We have a buyer-focused checklist: Surgical Robot Vendor Selection: Support Coverage, Software Upgrades, and Lifecycle.

Want to be notified when specs or pricing change for these robots? Drop your email.

Get updates:

Other comparisons

About this comparison

Ekso vs Sentante Endovascular Robotic System compares two robots in the surgical-medical category. All data is sourced from manufacturer spec sheets, verified deployments, and third-party filings; see our methodology for how the Robo Index is calculated.